313 GENES FOUND
Show / hide columns »
XML |
RDF |
TAB |
« prev | Page
of 7 | next »
KCNC3 Potassium channel, voltage gated Shaw related subfamily C, member 3 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCND1 Potassium channel, voltage gated Shal related subfamily D, member 1 FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Nucleus Mixed
KCND2 Potassium channel, voltage gated Shal related subfamily D, member 2 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCND3 Potassium channel, voltage gated Shal related subfamily D, member 3 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Mixed
KCNH1 Potassium channel, voltage gated eag related subfamily H, member 1 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Vesicles Tissue enriched
KCNH4 Potassium channel, voltage gated eag related subfamily H, member 4 Predicted membrane proteins Voltage-gated ion channels Tissue enhanced
KCNH5 Potassium channel, voltage gated eag related subfamily H, member 5 Predicted membrane proteins Voltage-gated ion channels Microtubules Mitotic spindle Tissue enhanced
KCNH6 Potassium channel, voltage gated eag related subfamily H, member 6 Predicted membrane proteins Voltage-gated ion channels Tissue enhanced
KCNH7 Potassium channel, voltage gated eag related subfamily H, member 7 Predicted membrane proteins Voltage-gated ion channels Tissue enriched
KCNH8 Potassium channel, voltage gated eag related subfamily H, member 8 Predicted membrane proteins Voltage-gated ion channels Tissue enhanced
KCNK1 Potassium channel, two pore domain subfamily K, member 1 Predicted membrane proteins Voltage-gated ion channels Vesicles Mixed
KCNK10 Potassium channel, two pore domain subfamily K, member 10 Predicted membrane proteins Tissue enhanced
KCNK12 Potassium channel, two pore domain subfamily K, member 12 Predicted membrane proteins Voltage-gated ion channels Tissue enriched
KCNK13 Potassium channel, two pore domain subfamily K, member 13 Predicted membrane proteins Voltage-gated ion channels Nuclear speckles Cell Junctions Tissue enhanced
KCNK16 Potassium channel, two pore domain subfamily K, member 16 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNK17 Potassium channel, two pore domain subfamily K, member 17 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNK18 Potassium channel, two pore domain subfamily K, member 18 Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels Not detected
KCNK2 Potassium channel, two pore domain subfamily K, member 2 FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels Mitochondria Cytosol Tissue enhanced
KCNK5 Potassium channel, two pore domain subfamily K, member 5 Predicted membrane proteins Transporters Voltage-gated ion channels Nucleus Tissue enhanced
KCNMA1 Potassium channel, calcium activated large conductance subfamily M alpha, member 1 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Tissue enhanced
KCNN4 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNQ1 Potassium channel, voltage gated KQT-like subfamily Q, member 1 Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNQ2 Potassium channel, voltage gated KQT-like subfamily Q, member 2 Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Endoplasmic reticulum Tissue enriched
KCNQ4 Potassium channel, voltage gated KQT-like subfamily Q, member 4 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Mixed
KCNQ5 Potassium channel, voltage gated KQT-like subfamily Q, member 5 Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Vesicles Tissue enhanced
KCNS2 Potassium voltage-gated channel, modifier subfamily S, member 2 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNS3 Potassium voltage-gated channel, modifier subfamily S, member 3 Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Golgi apparatus Plasma membrane Cytosol Tissue enhanced
KCNT1 Potassium channel, sodium activated subfamily T, member 1 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Group enriched
KCNT2 Potassium channel, sodium activated subfamily T, member 2 Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Vesicles Tissue enhanced
KCNU1 Potassium channel, subfamily U, member 1 Predicted membrane proteins Predicted secreted proteins Tissue enriched
MBOAT7 Membrane bound O-acyltransferase domain containing 7 Enzymes Predicted membrane proteins Cytosol Expressed in all
MCOLN1 Mucolipin 1 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Plasma membrane Cytosol Expressed in all
MCOLN2 Mucolipin 2 Predicted membrane proteins Transporters Voltage-gated ion channels Intermediate filaments Mixed
MCOLN3 Mucolipin 3 Predicted membrane proteins Transporters Voltage-gated ion channels Nucleoli Cytosol Tissue enhanced
MFSD7 Major facilitator superfamily domain containing 7 Predicted membrane proteins Mixed
MIP Major intrinsic protein of lens fiber Disease related genes Predicted membrane proteins Tissue enhanced
MRGPRX3 MAS-related GPR, member X3 G-protein coupled receptors Predicted membrane proteins Tissue enhanced
MT-ATP6 Mitochondrially encoded ATP synthase 6 Disease related genes Predicted membrane proteins Expressed in all
MYADM Myeloid-associated differentiation marker Predicted membrane proteins Transporters Nuclear speckles Expressed in all
NDC1 NDC1 transmembrane nucleoporin Predicted membrane proteins Transporters Nuclear membrane Plasma membrane Actin filaments Mixed
NIPAL3 NIPA-like domain containing 3 Predicted intracellular proteins Predicted membrane proteins Transporters Nucleoplasm Expressed in all
NOX1 NADPH oxidase 1 Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Group enriched
NOX4 NADPH oxidase 4 Predicted membrane proteins Transporters Nucleus Tissue enriched
NPC1 Niemann-Pick disease, type C1 Disease related genes Potential drug targets Predicted membrane proteins Transporters Expressed in all
NPC1L1 NPC1-like 1 FDA approved drug targets Predicted membrane proteins Tissue enhanced
OCSTAMP Osteoclast stimulatory transmembrane protein Predicted membrane proteins Not detected
OPN4 Opsin 4 G-protein coupled receptors Predicted membrane proteins Transporters Tissue enhanced
OPN5 Opsin 5 G-protein coupled receptors Predicted membrane proteins Tissue enriched
OPRD1 Opioid receptor, delta 1 FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Tissue enhanced
OPRK1 Opioid receptor, kappa 1 FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Group enriched
« prev | Page
of 7 | next »